DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

The Crystal

2017 年 10 月 04 日 8:00 上午 - 2017 年 10 月 05 日 8:00 下午

1 Siemens Brothers Way, Royal Victoria Dock, London, E16 1GB, United Kingdom

11th Annual Forum for Qualified Persons in Pharmacovigilance

This is the only forum designed for QPPVs by QPPVs, now in its 11th year and ever growing. This year’s objectives build on past successes and have been shaped by valuable feedback provided by participants.

Session 5: Inspections and Audits and Quality Management Systems

Session Chair(s)

Brian  Edwards, DrMed

Brian Edwards, DrMed

Director, International Society of Pharmacovigilance, United Kingdom

The QPPV is important in directing the interpretation of pharmacovigilance legislation and guidance. QPPVs have considerable flexibility but the basis of the decision must be transparent and properly documented. QPPVs must be able to explain the rationale of why a process is set up in a certain way or whether further changes are required to produce a compliant process. Challenges for quality include obtaining cross-functional ownership of issues and ensuring that all root causes remained addressed by corrective and preventive action plans. This session will explore the different experiences of the MAHs systems that both inspectors and auditors have recently had, how their activities have been supported by the QPPV and how they might expect the MAH to approach human error, communications between departments and other options, apart from audit, that the MAH might use to assess quality.

Speaker(s)

Kiernan  Trevett, MSC

Kiernan Trevett, MSC

Quality Policy Lead, Genentech, A Member of the Roche Group, United States

Identifying and Managing Non-Compliance in the PV System

Magnus  Ysander, MD

Magnus Ysander, MD

EU & UK QPPV & Head Pharmacovigilance Excellence, AstraZeneca, Sweden

Expectations on Inspections

Leen  Verbert

Leen Verbert

PV QA & Training Director, GlaxoSmithKline Biologicals, Belgium

PV Quality Management at the Affiliate

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。